RTOG 0529: A phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal

International Journal of Radiation Oncology Biology Physics

Volumn 86, Issue 1, 2013, Pages 27-33

  Kachnic, Lisa A ^a   Winter, Kathryn ^b   Myerson, Robert J ^c   Goodyear, Michael D ^d   Willins, John ^a   Esthappan, Jacqueline ^c   Haddock, Michael G ^e   Rotman, Marvin ^f   Parikh, Parag J ^c   Safran, Howard ^g   Willett, Christopher G ^h  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b RADIATION THERAPY ONCOLOGY GROUP   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DALHOUSIE UNIVERSITY   (Canada)

^e MAYO CLINIC   (United States)

^f SUNY DOWNSTATE MEDICAL CENTER   (United States)

^g BROWN UNIVERSITY   (United States)

^h DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5-FLUOROURACIL; ADVERSE EVENTS; CHEMO RADIATIONS; GASTROINTESTINAL TOXICITIES; INTENSITY MODULATED RADIATION THERAPY; METHODS AND MATERIALS; PLANNING TARGET VOLUMES; RADIATION QUALITY;

DISEASES; DRUG PRODUCTS; QUALITY ASSURANCE; RADIOTHERAPY; TUMORS;

PHYSICAL THERAPY;

FLUOROURACIL; MITOMYCIN;

ADULT; AGED; ALLERGY; ANUS CARCINOMA; ARTICLE; BLOOD CLOTTING DISORDER; CANCER PATIENT; CHEMORADIOTHERAPY; CONTROLLED STUDY; DERMATITIS; DOSE PAINTED INTENSITY MODULATED RADIATION THERAPY; DRUG WITHDRAWAL; ENDOCRINE DISEASE; FEMALE; GASTROINTESTINAL SYMPTOM; HEART ARRHYTHMIA; HUMAN; INFECTION; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; PAIN; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY CONTROL; RADIATION DOSE; REPRODUCTION; RESPIRATORY TRACT DISEASE; TREATMENT PLANNING; UROGENITAL TRACT DISEASE;

ADULT; AGED; AGED, 80 AND OVER; ANAL CANAL; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CARCINOMA, TRANSITIONAL CELL; CHEMORADIOTHERAPY; DOSE FRACTIONATION; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; GASTROINTESTINAL TRACT; HUMANS; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM STAGING; RADIATION INJURIES; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; UROGENITAL SYSTEM;

EID: 84876045190     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.09.023     Document Type: Article

References (15)

1. N.D. Nigro, V.K. Vaitkevicius, and B. Considine Jr. Combined therapy for cancer of the anal canal: A preliminary report Dis Colon Rectum 17 1974 354 356
2. Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research Lancet 348 1996 1049 1054
3. H. Bartelink, F. Roelofsen, and F. Eschwege Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups J Clin Oncol 15 1997 2040 2049 (Pubitemid 27209535)
4. M. Flam, M. John, and T.F. Pajak Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study J Clin Oncol 14 1996 2527 2539 (Pubitemid 26300120)
5. J.A. Ajani, K.A. Winter, and L.L. Gunderson Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: A randomized controlled trial JAMA 299 2008 1914 1921 (Pubitemid 351574921)
6. M.T. Milano, A.B. Jani, and K.J. Farrey Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: Toxicity and clinical outcome Int J Radiat Oncol Biol Phys 63 2005 354 361 (Pubitemid 41317151)
7. J.K. Salama, L.K. Mell, and D.A. Schomas Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: A multicenter experience J Clin Oncol 25 2007 4581 4586 (Pubitemid 350035316)
8. L.A. Kachnic, H.K. Tsai, and J.J. Coen Dose-painted intensity-modulated radiation therapy for anal cancer: A multi-institutional report of acute toxicity and response to therapy Int J Radiat Oncol Biol Phys 82 2012 153 158
9. H.K. Tsai, T.S. Hong, and J. Willins Dosimetric comparison of dose-painted intensity modulated radiation therapy vs. conventional radiation therapy for anal cancer J Clin Oncol 27 2006 18s(suppl; abstr 338)
10. R.J. Myerson, M.C. Garofalo, and I. El Naqa Elective clinical target volumes for conformal therapy in anorectal cancer: A radiation therapy oncology group consensus panel contouring atlas Int J Radiat Oncol Biol Phys 74 2009 824 830
11. R. Simon Optimal two-stage designs for phase II clinical trials Control Clin Trials 10 1989 1 10 (Pubitemid 19099520)
12. SAS/STAT software, version 9.2 of the SAS System for Windows 2009 SAS Institute Inc Cary, NC
13. L.K. Mell, D.A. Schomas, and J.K. Salama Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy Int J Radiat Oncol Biol Phys 70 2008 1431 1437 (Pubitemid 351417769)
14. M. John, T. Pajak, and M. Flam Dose escalation in chemoradiation for anal cancer: Preliminary results of RTOG 92-08 Cancer J Sci Am 2 1996 205 211
15. D.M. Cannon, and N.Y. Lee Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer Int J Radiat Oncol Biol Phys 70 2008 660 665 (Pubitemid 351199716)